Abstract
BackgroundThere is increasing concern about the occurrence of breakthrough/relapse of hepatitis B (HBV) and transaminase flare among anti-HBV core-positive (HBcAb) people living with HIV (PWH) who discontinue anti-HBV-containing antiretroviral drugs.Materials...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
